LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has ...
London, UK & Boston, MA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the ...
LONDON – [7 January 2026] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2026 Preview report, providing market forecasts for biopharma in 2026.
LONDON – [7 th January 2025] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma ...
Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan ...
This week we'll ring in a new year. Millions of people will contemplate New Year's Resolutions ranging from health to relationships to finances. These resolutions can be very motivating, if but for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results